UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026753
Receipt number R000028932
Scientific Title The protocol to control unstable tachycardia with landiolol in septic patients
Date of disclosure of the study information 2017/03/29
Last modified on 2017/03/29 10:26:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The protocol to control unstable tachycardia with landiolol in septic patients

Acronym

T-START(Tsukuba-septic tachycardia therapy trial)

Scientific Title

The protocol to control unstable tachycardia with landiolol in septic patients

Scientific Title:Acronym

T-START(Tsukuba-septic tachycardia therapy trial)

Region

Japan


Condition

Condition

Sepsis

Classification by specialty

Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the therapeutic effect of landiolol for acute septic patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The prevention of organ failure

Key secondary outcomes

survival rate for 30 and 60 days, Duration of intensive care unit and hospital stay etc.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Landiolol hydrochloride

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

probable sepsis (probable infection with positive qSOFA)
narrow-QRS tachycardia over 100 bpm in heart rate

Key exclusion criteria

cardiogenic shock
diabetic keto-acidosis or mebolic acidosis
high grade atrial-vetricular block, sick sinus syndrome
right ventricular failure with pulmonary hypertension
allergy against landiolol
severe heart failure
severe bronchial asthma
pregnant or lactating patients
patients under 100 bpm in heart rate
pheochromocytoma without any therapy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nobutake Shimojo

Organization

University of Tsukuba

Division name

Faculty of Medicine

Zip code


Address

1-1-1Tennodai, Univ, of Tsukuba, Igakuiryokei

TEL

0298533210

Email

nkshimojo@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nobutake Shimojo

Organization

University of Tsukuba

Division name

Faculty of Medicine

Zip code


Address

1-1-1Tennodai, Univ, of Tsukuba, Igakuiryokei

TEL

0298533210

Homepage URL


Email

nkshimojo@md.tsukuba.ac.jp


Sponsor or person

Institute

Emergency and Critical Care Medicine, Faculty of Medicine, University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, culture, sports, sciences and technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

èŒšćŸŽçœŒ


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2017 Year 03 Month 15 Day

Date of IRB


Anticipated trial start date

2017 Year 05 Month 01 Day

Last follow-up date

2019 Year 07 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 03 Month 29 Day

Last modified on

2017 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028932


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name